TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/12/2025
Voltar para busca
Dado oficial do USPTO
I-MAB BIOPHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
04/12/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
16/07/2019
Data de registro
25/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/01/2022
Última transação
04/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
13/04/2020
Primeiro uso no comércio
28/04/2020
Código do desenho
3
Tipo de titular
03
Localização do titular
ROCKVILLE, MD
Examinador
RINGLE,JAMES W
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B". Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters. The color white appearing in the mark represents transparent space and is not a part of the mark.
Titulares e representantes
Titulares
I-MAB BIOPHARMA US LIMITED
I-MAB BIOPHARMA CO., LTD
I-MAB
Representantes
Jacqueline Lesser Ice Miller LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancertumor suppressing agentsanti-cancer preparationspharmaceutical preparations for the treatment of immune system related diseases and disordersall comprising monoclonal antibodies
Classe 42
Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/04/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25/12/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
17/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/01/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
24/12/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/12/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
23/12/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/12/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
23/12/2021
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
23/12/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/12/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/12/2021
IUAF
USE AMENDMENT FILED
12/11/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/11/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2021
PUBO
PUBLISHED FOR OPPOSITION
07/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/08/2021
ALIE
ASSIGNED TO LIE
02/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/07/2021
GNRT
NON-FINAL ACTION E-MAILED
01/07/2021
CNRT
NON-FINAL ACTION WRITTEN
01/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/06/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
13/04/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
13/10/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/04/2020
GNSL
LETTER OF SUSPENSION E-MAILED
09/04/2020
CNSL
SUSPENSION LETTER WRITTEN
09/04/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/10/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2019
GNRT
NON-FINAL ACTION E-MAILED
12/09/2019
CNRT
NON-FINAL ACTION WRITTEN
12/09/2019
DOCK
ASSIGNED TO EXAMINER
10/09/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
24/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/07/2019
NWAP
NEW APPLICATION ENTERED
19/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace I-MAB BIOPHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.